Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis

NCT00291915 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis
Arthritis

Interventions

DRUG: Adalimumab
DRUG: Methotrexate

Sponsor

Goupe d'Etudes et de Recherche Clinique En Rhumatologie